Related by context. All words. (Click for frequent words.) 78 Papillary 76 leiomyomas 76 Metastases 74 prostate carcinoma 74 Carcinomas 74 Prostatic 74 Progenitor Cells 73 pulmonary metastases 73 metastatic malignant 73 Basal Cell 73 Adenoma 72 Malignant Melanoma 72 colorectal carcinoma 72 Inactivation 72 Allogeneic 72 Endothelial Cells 72 Autoantibodies 72 Epidermal Growth Factor Receptor 72 urothelial carcinoma 72 ductal carcinomas 72 Endothelial 72 renal cell carcinomas 71 Adenomas 71 Skeletal Muscle 71 Adjuvant Treatment 71 Prolongs Survival 71 Leukemias 71 Intracranial 71 Antigen Specific 71 Mucosal 71 Uterine 71 cisplatin resistant 71 Mouse Model 71 Peripheral Arterial 71 Ischemic 71 BRAF V#E 71 Small Intestine 71 murine model 71 Macrophage 71 surgically resected 71 papillary renal cell carcinoma 70 Refractory Hodgkin Lymphoma 70 HGPIN 70 NMIBC 70 Hematopoietic 70 nonmetastatic 70 syngeneic 70 Epithelial 70 Squamous Cell Carcinoma 70 breast carcinoma 70 Patients Receiving 70 urothelial 70 gastric carcinoma 70 fibrin deposition 70 Neoplasms 70 Renal Cell Carcinoma 70 Intracerebral 70 Patients Treated With 70 metastatic gastric 70 mucinous 70 Soft Tissue Sarcoma 70 HepG2 cells 70 Squamous 70 Factor Receptor 70 Modulates 70 grade squamous intraepithelial 70 treat benign prostatic 70 Lymphoid 70 Patients Undergoing 70 transabdominal 70 Immune Responses 70 metastatic colorectal 69 myomas 69 uterine cervix 69 myelodysplastic myeloproliferative diseases 69 adenomatous 69 mesangial 69 CD# + [001] 69 Placental 69 Estrogen Receptor 69 HER2 expression 69 Atypical Hemolytic Uremic Syndrome 69 Hepatic 69 Carcinoma 69 Alveolar 69 Peripheral Blood 69 Occlusive Disease 69 tumorigenicity 69 Autologous 69 Epstein Barr Virus EBV 69 hip osteonecrosis avascular 69 cervical lymph nodes 69 Adjuvant Chemotherapy 69 MR Angiography 69 Hormone Refractory Prostate Cancer 69 Antitumor Activity 69 B Cell Lymphoma 69 pancreatic lung 69 colorectal adenocarcinoma 69 LHRH receptor positive 69 metaplasia 69 TIMP 69 Gastric Cancer 69 Fibroblast 69 Infarct 69 leiomyoma 69 Shows Promise Against 69 Mitomycin C 69 bronchoalveolar lavage 69 Resection 69 Xenograft 69 peritoneal carcinomatosis 69 epithelial ovarian 68 Estradiol 68 Reperfusion Injury 68 Pivotal Clinical Trial 68 Transcatheter 68 carcinoembryonic antigen 68 #:#-# [023] 68 deep venous thromboses 68 skeletal metastases 68 Cyclooxygenase 2 68 Thromboembolic 68 Improves Outcomes 68 Left Ventricular 68 Valvular 68 Polymorphisms 68 Lymphocytic 68 complement inhibitor eculizumab 68 Regenerative Cells 68 BRAF V#E mutation 68 metachronous 68 Inhibits 68 neoplasias 68 papillary carcinoma 68 Myocardial 68 Xenografts 68 Peritoneal 68 Cell Transplants 68 Inflammatory Markers 68 CYT# potent vascular disrupting 68 prostate carcinomas 68 Caveolin 1 68 Legg Calvé Perthes disease 68 hamartomas 68 Germline 68 Dysplasia 68 Adenocarcinoma 68 Stromal 68 recurrent glioblastoma multiforme 68 urethral stricture 68 Radiofrequency Ablation 68 Lowers Risk 68 Oropharyngeal 68 Cystatin C 68 Tyrosine Kinase Inhibitor 68 hepatoma 68 Testis 68 Ectopic 68 Oncogenic 68 Postmenopausal Women 68 Microvascular 68 eccrine 68 Anthracycline 68 Clinical Outcome 68 mediated inhibition 68 Amniotic Fluid 68 hamartoma 68 immunohistochemical analysis 68 Preclinical Study 68 essential thrombocythemia ET 68 Postmenopausal 68 Upregulation 68 HCT# 68 apocrine 68 Cystectomy 68 normal karyotype 68 cervical lymph node 68 Hemangiomas 68 Proliferative 68 Duodenal 68 Complicated Skin 68 Embolization 68 thymectomy 68 pancreatic prostate 68 Nodules 68 endometrial hyperplasia 68 intraepithelial neoplasia 68 retinal ischemia 68 radiosensitivity 68 MGd 68 Parathyroid Hormone 68 resistant hormone refractory 68 hypervascular tumors 68 Hypertrophy 68 situ LCIS 68 Adenoviral 68 DU# [002] 68 pDC 68 Tumor Growth 68 hyperplastic 68 malignant ascites 68 #F FDG PET 68 Tumor Response 68 intrahepatic 68 Malignant Glioma 68 Ovarian Cancers 68 Histologic 68 Endometrial Cancer 68 Oral Fingolimod 68 Synovial 68 lactate dehydrogenase LDH 68 J Am Soc 68 tryptase 68 immunohistochemical staining 68 Histological 68 Patency 68 null mice 68 Squamous cell 68 Invasive Breast Cancer 68 advanced adenoma 68 Precancerous 67 transurethral 67 Treating Chronic 67 GSTP1 67 Renal Artery 67 Meets Primary Endpoint 67 trophoblastic 67 potent inducer 67 Mesenchymal 67 uterine tumors 67 Bone Metastases 67 #:#-# [031] 67 Contralateral 67 invasive lobular 67 Neovascular Age Related Macular 67 Drug Prevents 67 nodal metastasis 67 histopathologic examination 67 bFGF 67 Androgen 67 Levels Linked 67 paragangliomas 67 Tie2 67 Randomized Study 67 Microalbuminuria 67 esophageal carcinoma 67 Predict Response 67 alveolar epithelial cells 67 Intracellular 67 colorectum 67 Unfractionated Heparin 67 Extracellular Matrix 67 #:#-# [029] 67 pulmonary metastasis 67 prostate cancer CaP 67 liver metastasis 67 Hepatocellular 67 Prostate Cancer Progression 67 ERalpha 67 pT2 67 Angiographic 67 non resectable metastatic 67 cytoreduction 67 REMINDER ORLive Presents 67 VEGF induced 67 Study Evaluating 67 chemoresistant 67 lymphomas leukemias 67 aplasia 67 Dehydrogenase 67 Squamous Cell 67 Atherosclerotic 67 ASCUS 67 locoregional recurrence 67 epithelial tumors 67 epithelioid 67 Lupus Nephritis 67 Hypertrophic 67 ovarian carcinoma 67 Signaling Pathway 67 Leukocyte 67 Epithelial Cell 67 pleomorphic 67 Parathyroid 67 Streptococcus agalactiae 67 Prospective Randomized 67 HER2 Positive 67 thyroglobulin 67 GISTs 67 Clusterin 67 methylenetetrahydrofolate reductase 67 Breast Cancer Cells 67 colon carcinoma 67 NAVISTAR R 67 colorectal adenoma 67 mesenteric 67 serum prostate 67 Catheter Associated 67 Radiation Induced 67 Prophylactic Treatment 67 trophoblasts 67 Asymptomatic 67 Cell Proliferation 67 Hemodialysis Patients 67 Leydig cell 67 Fibrinogen 67 Subtypes 67 Attenuates 67 neointimal hyperplasia 67 Cytotoxic T 67 Meta Analysis 67 Hematological 67 Cancer Res 67 Intracoronary 67 protein tyrosine phosphatase 1B 67 Thiazolidinediones 67 renal cysts 67 underwent surgical resection 67 hemodynamically significant 67 Stenosis 67 Gene Mutation 67 Malignancies 67 chronic eosinophilic leukemia 67 Knee Osteoarthritis 67 precursor lesions 67 orthotopic 67 histological subtype 67 elevated transaminases 67 TRAIL R1 67 seminal vesicle 67 risk reducing salpingo 67 Esophageal 67 TIMP 1 67 malignant prostate 67 Non Alcoholic Fatty 67 Leydig cells 67 Cutaneous 67 transplantation HCT 67 Slow Progression 67 J Am Coll 67 Immunohistochemical staining 67 Metastatic Melanoma 67 Pharmacokinetics PK 67 Antitumor 67 androgen receptor AR 67 Cell Lymphoma 67 Breast Cancer Recurrence 67 cells overexpressing 67 Prolactin 66 Oxidative Stress 66 Diffuse Large B 66 umbilical vein 66 underwent resection 66 Improves Survival 66 pancreatic carcinoma 66 relapsed MM 66 breast carcinomas 66 Mouse Models 66 pituitary adenomas 66 Hyperplasia 66 invasive carcinomas 66 Test Detects 66 aneurysms AAA 66 squamous cell carcinoma SCC 66 ORLive Presents 66 VEGFR1 66 Naive Patients 66 Thromboembolism 66 Malignancy 66 Fibroblasts 66 Cancer Cells 66 tonsillar 66 Achieves Primary Endpoint 66 thyroid carcinoma 66 Dendritic Cells 66 keratoplasty 66 Genes Predict 66 pancreatic endocrine 66 Scintigraphy 66 epididymal 66 Stent Restenosis 66 allogeneic epidermal 66 Phase 2b Clinical Trial 66 Reduces Mortality 66 ADAMTS# 66 Hypotension 66 Hippocampal 66 neointimal 66 urothelial cancer 66 Colorectal Cancers 66 radioiodine therapy 66 pretransplant 66 Alkaline Phosphatase 66 Combination REOLYSIN R 66 Cutaneous T 66 External Beam 66 lumbar spine bone 66 neuroblastoma tumors 66 adjuvant radiotherapy 66 Hormone Receptor Positive 66 transurethral resection 66 kidney urologic 66 CYP#A# CYP#D# 66 allogeneic hematopoietic stem cell 66 desmoplastic 66 choriocarcinoma 66 Premature Aging 66 Lobular 66 Malformations 66 colorectal gastric 66 ADPKD 66 CP CPPS 66 Thymic 66 Degarelix 66 Homeostasis 66 Prognostic Value 66 neoplastic cells 66 Circulating Tumor Cells 66 Accelerated Partial Breast Irradiation 66 Endothelial Function 66 peritoneal fluid 66 submucosal 66 Mesenchymal Stem Cells 66 gastric adenocarcinoma 66 Chronic Sinusitis 66 thyrotropin 66 Prognostic significance 66 Immunohistochemical analysis 66 prostate TURP 66 Embolic 66 Glioma 66 Breast conserving 66 Reductase 66 PLX STROKE targeting 66 plasminogen activator inhibitor 66 ductal lobular 66 #:#-# [035] 66 clonogenic 66 See CLINICAL PHARMACOLOGY 66 Predict Risk 66 NeoLipid R 66 haematopoietic 66 breast endometrial 66 intravesical therapy 66 carcinoid tumor 66 Breast Tumors 66 Am J Cardiol 66 Anti Tumor Activity 66 HER2 HER2 66 underlying vasculopathy 66 histologic findings 66 Ultrasensitive 66 Relapsed Refractory 66 Vertebral Compression Fractures 66 inducible nitric oxide synthase 66 acid phosphatase PAP 66 metastatic lymph nodes 66 Pancreatic 66 Cancer Incidence Mortality 66 extramedullary 66 histologic subtype 66 Antiangiogenic 66 Intravascular 66 basal cell carcinoma BCC 66 BERKELEY CA UroToday.com 66 nutlin 3a 66 Minimally Invasive Procedure 66 PNET 66 fibroma 66 sarcomatoid 66 Ribavirin causes 66 Myelodysplastic Syndromes 66 Basal Cell Carcinoma 66 Coronary Artery 66 interstitial fibrosis 66 Implantation 66 myometrium 66 KRAS oncogene 66 Cytogenetic 66 downregulates 66 Heterozygous 66 autophagic 66 Cytotoxicity 66 vestibular schwannomas 66 alpha1 antitrypsin deficiency 66 Hepatocellular Carcinoma 66 Calcification 66 invasive ductal 66 RRM1 66 graft occlusion 66 Carotid Stenting 66 Dermatol 66 Axillary 66 pathologic examination 66 Breast Tissue 66 osteoid 66 Platelet Derived Growth 66 Intravitreal 66 Relapsing Multiple Sclerosis 66 proto oncogene 66 Metastatic 66 Epidermal 66 ovary uterus 66 Endothelium 66 triiodothyronine 66 cholelithiasis 66 hemorrhage necrosis 66 Monocyte 66 Ultrasonography 66 Chemoradiation 66 Urinary tract 66 Slows Progression 66 #-# Full Text 66 Retinoic Acid 66 urogenital tract 66 thrombocytosis 66 Interferon Beta 66 Coronary Arteries 66 Preclinical Models 66 artery embolization 66 Hepatocytes 66 #F FDG 66 Secretase 66 osteoid osteoma 66 lung esophageal 66 Clinical Trial Results 66 Cathepsin B 66 Immunotherapeutic 66 ERK1 2 66 AGTR1 66 hyperplasia BPH 66 GNAQ 66 progesterone receptor negative 66 Capsular 66 upregulates 66 Endometrial cancer 66 constitutively expressed 66 Initiates Clinical Trial 66 Intraocular 66 transthyretin 66 LNCaP cells 66 Distal 65 Immunohistochemical 65 tumoral 65 CIN2 + 65 von Hippel Lindau 65 Subclinical 65 Quantitation 65 retroperitoneal 65 Aneurysm Repair 65 Thrombotic 65 BRAF gene mutations 65 5 Fluorouracil 65 lobular carcinoma 65 metastatic pancreatic 65 esophageal gastric 65 baseline LDH 65 K ras mutations 65 Stomatitis 65 immunostaining 65 Endothelial Cell 65 Pooled Analysis 65 #:#-# [033] 65 Salivary 65 Septic Shock 65 Arrhythmogenic 65 Phosphorylation 65 choroidal 65 prostatic tissue 65 specific antigen PSA 65 lymphocytosis 65 osteolytic 65 cutaneous melanoma 65 Advanced Renal Cell 65 hMG 65 explants 65 localized renal 65 xenograft model 65 immunoblotting 65 meningeal 65 pancreatic adenocarcinoma 65 pT3 65 NSCLC tumors 65 Vulvar 65 Sonographic 65 Anti Tumor 65 Staphylococcus epidermidis 65 Myeloid 65 Shows Promising 65 LPS induced 65 exocrine 65 cytokeratin 65 CEACAM1 65 Adjunctive 65 VEGF expression 65 Glucocorticoid 65 J Am Acad 65 oral squamous cell 65 molecule epidermal 65 Prognostic Significance 65 BRCA2 mutation carriers 65 Novel Small Molecule 65 alkaline phosphatase ALP 65 neuritic 65 Estrogens 65 Adjuvant chemotherapy 65 selective modulator 65 intracavitary 65 synovial tissue 65 lymphangiogenesis 65 lung adenocarcinomas 65 Chronic Pelvic Pain 65 Hyperlipidemia 65 hepatocellular carcinomas 65 renal carcinoma 65 Enterobacter cloacae 65 Physiology Seminar 65 nodal metastases 65 endometrial 65 intracerebral 65 subependymal giant cell 65 xenograft tumors 65 prostaglandin E 65 bladder prostate 65 gadolinium enhanced 65 steroidogenesis 65 J Clin 65 bronchogenic 65 bronchoalveolar lavage fluid 65 cell carcinomas 65 soluble tumor necrosis 65 Fracture Risk 65 leukoencephalopathy 65 Antithrombin 65 neovascularisation 65 induced apoptosis 65 neovasculature 65 hypothalamic pituitary 65 Humeral 65 fallopian tube carcinoma 65 hormone receptor negative 65 platelet dysfunction 65 BRCA deficient 65 Acute Renal Failure 65 TUNEL 65 hepatocellular carcinoma liver 65 mU liter 65 pulmonary alveolar 65 Renal Impairment 65 recurrent metastatic 65 mammographic density 65 mutated K ras 65 Androgen Deprivation Therapy 65 Polymerase Inhibitor 65 sunitinib Sutent 65 Am J Clin 65 R Saizen R 65 colorectal liver metastases 65 abnormal p# 65 invasive lobular carcinoma 65 Non Invasive Treatment 65 bladder ovarian 65 squamous intraepithelial lesions 65 Pegylated Liposomal Doxorubicin 65 Surgical Treatment 65 J Nutr 65 Trial Evaluating 65 Cortical 65 Hematologic 65 Improve Survival 65 Successfully Treated 65 endoluminal stent graft 65 Clin Chem 65 cell adhesion molecule 65 papillary thyroid carcinoma 65 Low Dose 65 Localized Prostate Cancer 65 Situ Hybridization 65 Controlled Study 65 Immunohistochemistry 65 Hemorrhagic 65 BRAF mutant 65 intimal hyperplasia 65 Kinase Inhibitors 65 Tumor Cell 65 myeloperoxidase 65 Aurora Kinase 65 nonproliferative 65 benign prostatic hyperplasia enlarged 65 Minimally Invasive Treatment 65 Therapeutic Effects 65 bullous 65 eosinophil count 65 ductal breast cancer 65 Node Positive 65 proximal colon 65 immunoreactivity 65 Delayed Graft Function 65 Recombinant Human 65 plasma pharmacokinetics 65 uterus fallopian tubes 65 vWF 65 Cypher Sirolimus 65 Contrast Enhanced 65 TNF Tumor Necrosis Factor 65 oesophageal adenocarcinoma 65 Hypertensive Patients 65 SGPT 65 Monoclonal 65 monocytic 65 gene polymorphism 65 Biocompatibility 65 immunohistochemical 65 STRIDE PD 65 hepatocellular 65 Fluorouracil 65 Immunosuppressive 65 jejunal 65 degranulation 65 Disease Progression 65 Gastrointestinal Tract 65 beta estradiol 65 monocytes macrophages 65 paraganglioma 65 Uterine Cancer 65 Secondary Hyperparathyroidism 65 myopathies 65 Glioblastoma Multiforme 65 Abdominal Fat 65 fallopian tube cancers 65 biochemical relapse 65 nephrogenic 65 thymoma 65 recurrent ovarian 65 Breast Cancers 65 Motexafin Gadolinium 65 gastric corpus 65 CT Angiography 65 Anaplastic 65 TRAIL R2 65 Brain Metastases 65 biliary tract cancer 65 Etiology 65 Radical Prostatectomy 65 unresectable tumors 65 gamma glutamyl 65 Elevated serum 65 mediastinitis 65 MAGE A3 65 FUSILEV enhances 65 endometrial carcinoma 65 ductal adenocarcinoma 65 Coronary Angiography 65 Survival Benefit 65 cytotoxic effects 65 Castration Resistant Prostate Cancer 65 Chronic Lymphocytic Leukemia CLL 65 proximal tubule 65 FDG uptake 65 lung pancreatic 65 Neuronal 65 sFlt 1 65 Conjugated 65 Thrombin 65 Decitabine 65 breast ovary 65 choroidal neovascularization 65 SCID mice 65 achieved CCyR 65 Infectivity 65 Aortic Valve 65 testicular germ cell 65 vimentin 65 Chronic Heart Failure 65 transfusion syndrome 65 myocardial necrosis 65 MSH2 65 p# biomarker 65 castrate resistant 65 occlusive disease 65 pleurodesis 65 Induces 65 polypoid 65 Skin Structure Infections 65 brivanib 65 Urethral 65 Proves Effective 65 bronchoalveolar lavage BAL 65 hypereosinophilic syndrome 65 thyroid carcinomas 65 pheochromocytomas 65 superficial femoral 65 Placebo Controlled Study 65 Treatment Reduces 65 MALT lymphoma 65 F FDG PET 65 Nephrol 65 PEGylated Fab fragment 65 steroidogenic 65 parathyroidectomy 65 FGFR3 65 cTnI 65 relapsed ALL 65 androgen dependent 65 lichen planus 65 Pleural 65 Chronic Hepatitis C 65 Heart Failure Patients 65 allogeneic HSCT 65 gastric cardia 65 Invasive Fungal Infections 65 resected pancreatic cancer 65 Testes 65 needle aspiration 65 MMP2 65 intestinal mucosal 65 Mg Usa 64 Aggressive Prostate Cancer 64 myelofibrosis polycythemia vera 64 interleukin IL -# 64 Increases Risk 64 Aeromonas 64 Advanced Melanoma 64 grade cervical intraepithelial 64 microvessel density 64 keloid scarring 64 Novel Inhibitor 64 bronchial epithelial cells 64 artificial arteriovenous dialysis 64 nonmelanoma 64 endometrioid 64 lexidronam injection 64 total abdominal hysterectomy 64 pelvic lymphadenectomy 64 Relapsing Remitting Multiple Sclerosis 64 Tumor Suppressor 64 Cancer Patients Treated 64 Diabetic Neuropathy 64 Premenopausal Women 64 Successfully Treats 64 extrahepatic 64 Therapeutic Efficacy 64 Smooth Muscle 64 polycythemia vera PV 64 Biliary 64 Nano Particles 64 Histopathologic 64 Clinical Relevance 64 Fungal Infections 64 heparanase 64 Prognostic 64 tumor xenograft models 64 J. Clin 64 hypermethylated 64 Genotypes 64 ErbB2 positive 64 mL/min/#.# m 2 64 Axonal 64 malignant cancerous 64 clinicopathological features 64 Metastatic Prostate Cancer 64 Kinase Inhibitor 64 appendiceal 64 Multiple Myeloma MM 64 nodular lesions 64 RhD positive 64 GSTT1 64 Activator CK # 64 Azacitidine 64 acute humoral rejection 64 chemo resistant 64 Benign Prostatic Hyperplasia BPH 64 Pelvic Inflammatory Disease 64 Cell Carcinoma 64 Novel Treatments 64 Antigen CEA 64 vaginalis 64 Comorbidities 64 Beta Amyloid 64 Chronic Myelogenous Leukemia 64 operable breast cancer 64 Controlled Trial 64 Sevelamer 64 Transplant Rejection 64 Emboli 64 Cardiac Troponin 64 Spinal Fluid 64 HUVEC 64 type plasminogen activator 64 castration resistant hormone refractory 64 pathophysiological effects 64 Pegylated 64 Liver Injury 64 acinar 64 Randomized Phase II 64 adrenal cortex 64 haematologic 64 perioperative complications 64 FASEB J. 64 Adipose Derived Stem Cells 64 aminotransferase 64 Sipuleucel T 64 Dose Response 64 LH FSH 64 hypothalamus pituitary 64 bladder carcinoma 64 Neovascularization 64 SSc 64 Prednisone Against Refractory 64 pegylated liposomal doxorubicin 64 Carotid artery 64 precancerous cervical 64 Arch Neurol 64 EGFR mutant 64 renal pelvis 64 Antiviral Therapy 64 Fallopian Tube 64 Catheter Ablation 64 Prenatal Diagnosis 64 Benign Prostatic Hyperplasia 64 bladder tumors 64 ischemia induced 64 colorectal tumor 64 Lymph Node 64 Hepatitis B Virus 64 Adiposity 64 renal biopsy 64 Effectively Treats 64 WT1 64 Vidaza ® 64 thyroid nodules 64 Fas ligand 64 contralateral breast 64 atypical Hemolytic Uremic Syndrome 64 transthoracic 64 hypoperfusion 64 hyperplasia 64 gonadotropins 64 Subgroup analysis 64 Protelos R 64 hypertrichosis occurred 64 Inhibitory 64 Pivotal Trial 64 Cardiol 64 Pericardial 64 lactate dehydrogenase 64 Renal Cell Cancer 64 isoenzyme 64 carmustine 64 Inflammatory Diseases 64 Diabetic Foot Ulcer 64 Trichophyton rubrum 64 methicillin susceptible Staphylococcus aureus 64 Introgen ADVEXIN 64 colorectal neoplasms 64 Ultrasonographic 64 Adjuvant Therapy 64 Tumor Necrosis Factor 64 Primary Hypercholesterolemia 64 Angina pectoris 64 glomerular 64 Neoadjuvant 64 biliary tree 64 p# deficient 64 Cell Lymphoma CTCL 64 histologic examination 64 enucleated 64 parathyroid carcinoma 64 Adipose Tissue 64 HEK# 64 HER2 amplified 64 biliary tract 64 intraductal 64 tumors GIST 64 Oral Mucositis 64 oligodendrogliomas 64 pancreatic islet cell 64 schwannomas 64 Replacement Therapy 64 Long Term Efficacy 64 ovarian colon 64 metastatic renal 64 Hepatocyte 64 fetal chromosomal 64 BRCA2 carriers 64 bioavailable testosterone 64 ANCA associated 64 epithelia 64 ischemia reperfusion injury 64 Acute myeloid leukemia 64 Tumor Suppressor Gene 64 INCB# [003] 64 metalloproteinase 64 artery stenosis 64 renal parenchyma 64 Rb2 64 Regenerative Cell 64 autosomal dominant polycystic kidney